About this course
Nonalcoholic fatty liver disease (NAFLD) is the initial stage of the liver disease spectrum that is still reversible, thus it is important to manage it from the outset to prevent progression to its more severe forms. It is asymptomatic, therefore screening for the disease is important. This e-learning module summarizes the risk factors, clinical manifestations, screening, diagnosis, and current non-pharmacologic treatment options, as well as the emerging pharmacologic options for NAFLD.
Upon completion of the educational activity, health care providers should be able to
- Identify the warning signs of NAFLD and the various screening modalities available
- Apply nonpharmacological approaches to reverse or prevent NAFLD progression
- Risk factors for the development of NAFLD
- Screening and diagnosis of NAFLD
- Non-pharmacologic management of NAFLD
1 CME Point Available
- This module is accredited for 1 CME Point for medical practitioners enrolled in The Medical Council of Hong Kong’s Continuing Medical Education Programme for Practising Doctors who are not taking CME for Specialists.
- This module is accredited for both Hong Kong Doctors Union (HKDU) members and non-members.
- This module is accredited for 1 CME Point for fellows of the Hong Kong College of Physicians.
- Please note that this module will not earn CME credit for fellows of colleges not listed here.
- A certificate can be downloaded upon successful completion of the quiz. Please use the information on the certificate to claim your CME points.